IMBM was awarded two bilateral grants. One program is aimed at furthering work on a biosurfactant produced by an enzyme identified through screening of metagenomic libraries (SA-Germany; Dr. Anita Burger). The second program (SA-France; Prof Marla Trindade) is to develop phage-based therapies targeting the entomopathogenic bacterium Paenibacillus larvae responsible for American Foulbrood disease affecting honeybees as well as knocking out the plant pathogenic bacterium (Xylella fastidiosa) found on olive trees. Both programs will see researchers from their respective countries exchange for a period of two months to perform either sampling for phages (SA-France) or training (SA-Germany) with respect to construction and screening of metagenomic libraries and characterization of biosurfactants. Both programs are set to start early in 2017.
Institute for microbial Biotechnology and Metagenomics
IMBM, Core2, Life Science Building,
University of the Western Cape,
Robert Sobukwe rd.,
Bellville,
7535,
Cape Town,
South Africa,
Tel: +27 21 9599725-
News
- Done and Dusted – UWC Flow cytometry course 2024
- Microbial Biobank Provides Training Opportunities for the Next Generation of Microbial Biotechnologists
- 1 June 2024, the official start of an exciting multi-national Green ERA-Hub project, AMD-Gas in maize.
- DIPLOMICS launches 1KSA initiative with IMBM as one of the core labs
- Our Director, Prof Trindade, has earned a distinguished place in South Africa’s most prestigious science community as an ASSAf member.
Twitter
DIPLOMICS
BlueRemediomics